The ability to evaluate the efficacy of a given treatment for cancer is critical in achieving the best prognosis and care for patients. However, most standard methods of treatment response evaluation rely on visualizing a change in tumor size, which often occurs months after treatment begins.

Fighting cancer is a tough-enough ordeal for patients and clinicians alike. But waging war against an eminently deadly ...